IRIS
PREZIOSA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 773
NA - Nord America 583
AS - Asia 349
SA - Sud America 20
AF - Africa 14
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 573
SE - Svezia 334
IT - Italia 143
SG - Singapore 140
RU - Federazione Russa 125
CN - Cina 114
DE - Germania 56
FI - Finlandia 29
IN - India 22
IE - Irlanda 19
IR - Iran 19
TR - Turchia 12
EG - Egitto 11
HK - Hong Kong 11
FR - Francia 10
BE - Belgio 9
NL - Olanda 9
CA - Canada 8
ES - Italia 8
PL - Polonia 8
JP - Giappone 7
SA - Arabia Saudita 7
AU - Australia 6
PT - Portogallo 6
PY - Paraguay 6
AR - Argentina 5
CL - Cile 5
GB - Regno Unito 5
NO - Norvegia 5
TW - Taiwan 5
CY - Cipro 4
KR - Corea 4
CO - Colombia 3
CZ - Repubblica Ceca 3
NG - Nigeria 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
EU - Europa 2
MX - Messico 2
NZ - Nuova Zelanda 2
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
PK - Pakistan 1
Totale 1.749
Salva come PNG Salva come JPEG
Città #
Princeton 97
Lawrence 96
Ashburn 83
Singapore 82
Shanghai 72
Moscow 56
Milan 54
New York 48
Boardman 46
Rome 25
Helsinki 24
Dublin 18
Radebeul 15
Dallas 10
Los Angeles 10
Washington 10
Chennai 9
Ankara 7
Brussels 7
Siena 7
Tehran 7
Düsseldorf 6
Giza 6
Vänersborg 6
Ahmedabad 5
Asunción 5
Oslo 5
Seattle 5
Amsterdam 4
Cairo 4
Dresden 4
Istanbul 4
Krakow 4
Lappeenranta 4
Marostica 4
Naples 4
Nuremberg 4
Philadelphia 4
Poznan 4
Rio Mayo 4
Riyadh 4
Shenzhen 4
Berlin 3
Città di Castello 3
Dammam 3
Dongguan 3
Frankfurt am Main 3
Genoa 3
Hanover 3
Lagos 3
Melbourne 3
Missaglia 3
New Taipei 3
Pisa 3
Pittsburgh 3
Pune 3
Regina 3
Santiago 3
Scurzolengo 3
Stockholm 3
Tokyo 3
Tranemo 3
Abu Dhabi 2
Acton 2
Barwāni 2
Bogotá 2
Boston 2
Calgary 2
Canterbury 2
Carmel 2
Castellammare di Stabia 2
Chandler 2
Chicago 2
Chillan 2
Chongqing 2
Chuo 2
Cleveland 2
Duisburg 2
Ferrara 2
Foresto Sparso 2
Hepstedt 2
Hok 2
Hong Kong 2
Lisbon 2
Madison 2
Madrid 2
Mexico City 2
Milwaukee 2
Mountain View 2
Munich 2
Paris 2
Prague 2
Reggio Emilia 2
Reims 2
Rotterdam 2
Sassuolo 2
Segovia 2
Sejong 2
St Petersburg 2
Taipei 2
Totale 1.013
Salva come PNG Salva come JPEG
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 132
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 56
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 50
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 32
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 29
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 29
Functional and structural MRI correlates of executive functions in multiple sclerosis 28
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 28
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 27
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 26
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 26
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 25
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 23
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 22
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 20
Association between pathological and MRI findings in multiple sclerosis 20
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 20
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 19
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 19
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 19
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 18
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 18
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 17
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 17
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study 17
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 17
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 17
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 17
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 17
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study 17
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 17
Quantitative MRI adds to neuropsychiatric lupus diagnostics 17
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 17
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 17
Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity 17
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 16
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis 16
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 15
Information from ecological momentary assessments leads to over-medicalization: No 15
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective 15
The current role of MRI in differentiating multiple sclerosis from its imaging mimics 15
Brain mapping in multiple sclerosis: Lessons learned about the human brain 15
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 15
Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study 15
COVID-19 will change MS care forever – No 15
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 14
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 14
Brain reserve against physical disability progression over five years in multiple sclerosis 14
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study 14
Action observation training modifies brain gray matter structure in healthy adult individuals 14
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 14
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 14
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 14
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis 14
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 13
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 13
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 13
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 13
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 13
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience 13
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 13
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 12
Can post-mortem MRI be used as a proxy for in vivo? A case study 12
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 12
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders 12
The role of DTI in multiple sclerosis and other demyelinating conditions 12
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 12
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 12
Identifying Progression in Multiple Sclerosis: New Perspectives 12
Measurement of white matter fiber-bundle cross-section in multiple sclerosis using diffusion-weighted imaging 12
Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment 12
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis? 12
Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study 12
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 12
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 11
MRI predicts cognitive training effects in multiple sclerosis 11
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 11
Il ruolo della risonanza magnetica nel monitoraggio clinico e della risposta terapeutica 11
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 11
DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS 11
Microstructural MR Imaging Techniques in Multiple Sclerosis 11
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study 11
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 11
Multiple sclerosis 11
Functional and structural plasticity following action observation training in multiple sclerosis 11
Lifespan normative data on rates of brain volume changes 11
Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and mri study 11
Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study 11
Effects of Natalizumab and Fingolimod on Clinica, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 11
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion 10
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 10
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 10
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 10
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. 10
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 10
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 10
Gray matter damage predicts the accumulation of disability 13 years later in MS. 10
Two-year regional grey and white matter volume changes with natalizumab and fingolimod 10
Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria 10
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection 10
Totale 1.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 4 2 0 1 0 5 1 0 0
2020/202151 0 0 12 2 1 16 4 1 7 2 5 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/2025328 250 78 0 0 0 0 0 0 0 0 0 0
Totale 2.029